Cognition Therapeutics, Inc. (CGTX) vs Telomir Pharmaceuticals, Inc. Common Stock (TELO)

A side-by-side comparison of Cognition Therapeutics, Inc. and Telomir Pharmaceuticals, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cognition Therapeutics, Inc. logo
CGTX
Cognition Therapeutics, Inc.
$84M
$0.94HealthcareDelayed quote: Oct 6, 2026, 3:45 PM EDT
Telomir Pharmaceuticals, Inc. Common Stock logo
TELO
Telomir Pharmaceuticals, Inc. Common Stock
$83M
$1.20HealthcareDelayed quote: Oct 6, 2026, 3:44 PM EDT

Total return — CGTX vs TELO

growth of $100 · dividends reinvested · last 3y
CGTX -58.3% (-25.3%/yr)TELO -82.7% (-44.3%/yr)CGTX compounded faster over this window
050100150Start $10020252026$42$17
CGTX TELO

CGTX vs TELO: by the numbers

  • •CGTX is the larger company ($84M vs $83M market cap).

Metrics side by side

Valuation

MetricCGTXTELO
P/B ratio2.5516.40

Profitability

MetricCGTXTELO
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-50.80%-116.74%
ROIC-109.43%-120.93%

Go deeper

Full CGTX analysisFull TELO analysisInteractive comparison tool

Dig into the metrics

Cognition Therapeutics ROETelomir Pharmaceuticals, Inc. Common Stock ROECognition Therapeutics operating marginTelomir Pharmaceuticals, Inc. Common Stock operating marginCognition Therapeutics revenue growthTelomir Pharmaceuticals, Inc. Common Stock revenue growthCognition Therapeutics free cash flowTelomir Pharmaceuticals, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.